Entries are reviewed over a two-stage judging process by a highly skilled and experienced panel of judges, the majority of whom are experts from the pharma industry (holding marketing, digital or medical roles), joined by creative, digital and technical experts from agencies. We recognise and understand the sensitive nature of the information submitted in your entries; therefore we require all judges to sign a legally binding confidentiality agreement before the appointment.
Our Head Judge will ensure all processes are adhered to and that judging is fair and balanced and will make any final decisions if required.
Judging phase 1: Online review
The panel is divided into subgroups according to their expertise and experience and these separate judging panels will review all entries in their relevant categories online.
No one judge reviews more than three separate categories.
As some entries are viewed via a URL supplied by entrants during the entry process, please ensure your entries remain online and accessible until 29 January 2022
The decision of the judges in all matters is final and they reserve the right to move entries into other categories if appropriate. (you will be informed if this happens) Whole categories may be merged with others or removed altogether (and fees refunded if appropriate) if insufficient entries are received.
Judging phase 2: Judging days
A number of entries from each category will be shortlisted based on online judging.
Over the course of 2 / 3 days, the judges will gather online to review, individually score, debate and ultimately decide the best work, from the shortlisted online results, be it print or digital in each of the categories. This culminates in awarding Gold, Silver and Bronze accordingly.
For both rounds, your entry will be judged on the judging criteria outlined on the website.